Ellen Capito-Wightman to be Profiled in Exclusive Registry
Ellen Capito-Wightman started The Artac Seel Company in 1996

/Cancer News Articles/ -- STONINGTON, CT, January 3, 2011, Ellen Capito-Wightman, President and Chief Executive Officer of The Artac Seel Company, has been recognized by Cambridge Who's Who for demonstrating dedication, leadership and excellence in business management.

Mrs. Capito-Wightman has 29 years of overall professional experience. At The Artac Seel Company, she is responsible for overseeing immunology, oncology, hematology and stem cell research. She started her career in the pharmaceutical industry in 1981 as a medical information scientist. Shortly thereafter, she was promoted to assistant director, where she oversaw the transplantation clinical data/programs. She then moved into clinical research and medical affairs.

In 1985, Mrs. Capito-Wightman received a master's degree in Pharmaceutical Business/Immunology from Seton Hall University. She received a Bachelor of Science in Biology and Chemistry in 1981 from Caldwell College, and is a member of the Society of Toxicology, the Association of Clinical Research Professionals, the Drug Information Association and ASCO.

The Artac Seel Company provides pharmaceuticals, consulting and recruiting for pharmaceutical, biotechnology, medical devices and clinical research organizations worldwide. For more information, visit http://www.artacseel.com.

Press Release Contact Information:

Ellen Campbell
Cambridge Who's Who
Public Relations
498 RXR Plaza, West Tower
Uniondale, NY
USA 11556
Voice: 516-535-1515 x4266
Website: Visit Our Website